![Matthew Hawryluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 81 737 $ in data 31/05/2026
Matthew J.
Hawryluk is currently Independent Director at Axe Compute, Inc. since 2022, Director at Ourotech, Inc., and Chief Business Officer at Prime Medicine, Inc. starting in 2025.
Formerly, Dr. Hawryluk was Vice President-Corporate & Business Development at Foundation Medicine, Inc. and Chief Business Officer & Executive Vice President at Gritstone bio, Inc. from 2015 to 2024.
Education includes undergraduate studies at the University of Notre Dame, an MBA from Tepper School of Business, and a doctorate from the University of Pittsburgh School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AXE COMPUTE INC. 0,35% | 20/04/2026 | 11.727 ( 0,35% ) | 81 737 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PRECISION THERAPEUTICS INC | Direttore/Membro del Consiglio | 29/11/2022 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 03/11/2025 |
Ourotech, Inc.
 Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 31/12/2024 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predictive Oncology, Inc.
 Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Ourotech, Inc.
Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
